Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
The effects of oral contraceptives on coagulation in 258 nonsmoking and in 190 smoking women were determined. In smokers and in nonsmokers taking oral contraceptives, fibrinogen and fibrinopeptide A concentrations were higher than in oral contraceptive nonusers. In nonsmokers, oral contraceptives increased antithrombin III activity. The effects on coagulation of oral contraceptives with a different ethinylestradiol content (from 35 mcg to 20 mcg) were then evaluated in 333 of these women. The biggest changes in coagulation were observed in smokers taking the preparation with the highest estrogen content. Reduction of the ethinylestradiol dose caused a decrease of the changes in coagulation induced by oral contraceptives both in smokers and nonsmokers. These results might suggest that during oral contraception the coagulation system is affected mainly in smokers and that the decrease of the estrogen dose might lower the effects of the association of smoking and oral contraception on coagulation.
Fruzzetti
F
F
Department of Obstetrics and Gynecology, University of Pisa, School of Medicine, Italy.
Ricci
C
C
Fioretti
P
P
D000293:Adolescent; D000328:Adult; D000990:Antithrombin III / Q000378:metabolism; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005344:Fibrinopeptide A / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D008875:Middle Aged; D011517:Prothrombin Time; D012907:Smoking / Q000097:blood*
D003276:Contraceptives, Oral; D005344:Fibrinopeptide A; D004997:Ethinyl Estradiol; D000990:Antithrombin III; D005340:Fibrinogen